Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance at Dec. 31, 2021	$ 552,820	$ 35	$ 413,180	$ (1,018)	$ 140,623
Beginning balance (in shares) at Dec. 31, 2021		35,466,001
Stock-based compensation	4,193		4,193
Common stock issued upon exercises of options	333	$ 1	332
Common stock issued upon exercises of options (in shares)		50,911
Currency translation adjustment	(550)			(550)
Net Income (Loss)	69,582				69,582
Ending balance at Mar. 31, 2022	626,378	$ 36	417,705	(1,568)	210,205
Ending balance (in shares) at Mar. 31, 2022		35,516,912
Beginning balance at Dec. 31, 2021	552,820	$ 35	413,180	(1,018)	140,623
Beginning balance (in shares) at Dec. 31, 2021		35,466,001
Net Income (Loss)	75,208
Ending balance at Jun. 30, 2022	637,301	$ 36	423,743	(2,309)	215,831
Ending balance (in shares) at Jun. 30, 2022		35,575,323
Beginning balance at Dec. 31, 2021	552,820	$ 35	413,180	(1,018)	140,623
Beginning balance (in shares) at Dec. 31, 2021		35,466,001
Net Income (Loss)	96,700
Ending balance at Dec. 31, 2022	663,332	$ 36	435,665	(9,644)	237,275
Ending balance (in shares) at Dec. 31, 2022		35,611,219
Beginning balance at Mar. 31, 2022	626,378	$ 36	417,705	(1,568)	210,205
Beginning balance (in shares) at Mar. 31, 2022		35,516,912
Stock-based compensation	5,760		5,760
Common stock issued upon exercises of options	278		278
Common stock issued upon exercises of options (in shares)		58,411
Currency translation adjustment	(741)			(741)
Net Income (Loss)	5,626				5,626
Ending balance at Jun. 30, 2022	637,301	$ 36	423,743	(2,309)	215,831
Ending balance (in shares) at Jun. 30, 2022		35,575,323
Beginning balance at Dec. 31, 2022	663,332	$ 36	435,665	(9,644)	237,275
Beginning balance (in shares) at Dec. 31, 2022		35,611,219
Stock-based compensation	5,807		5,807
Common stock issued upon exercises of options	578		578
Common stock issued upon exercises of options (in shares)		149,408
Currency translation adjustment	(2,006)			(2,006)
Unrealized loss on available-for-sale securities	102			102
Net Income (Loss)	(15,551)				(15,551)
Ending balance at Mar. 31, 2023	652,262	$ 36	442,050	(11,548)	221,724
Ending balance (in shares) at Mar. 31, 2023		35,760,627
Beginning balance at Dec. 31, 2022	$ 663,332	$ 36	435,665	(9,644)	237,275
Beginning balance (in shares) at Dec. 31, 2022		35,611,219
Common stock issued upon exercises of options (in shares)	152,523
Net Income (Loss)	$ (49,851)
Ending balance at Jun. 30, 2023	623,526	$ 36	449,232	(13,166)	187,424
Ending balance (in shares) at Jun. 30, 2023		35,781,919
Beginning balance at Mar. 31, 2023	652,262	$ 36	442,050	(11,548)	221,724
Beginning balance (in shares) at Mar. 31, 2023		35,760,627
Stock-based compensation	6,964		6,964
Common stock issued upon exercises of options, ESPP purchases, and release of restricted stock units (in shares)		21,292
Common stock issued upon exercises of options, ESPP purchases, and release of restricted stock units	218		218
Currency translation adjustment	104			104
Unrealized loss on available-for-sale securities	(1,722)			(1,722)
Net Income (Loss)	(34,300)				(34,300)
Ending balance at Jun. 30, 2023	$ 623,526	$ 36	$ 449,232	$ (13,166)	$ 187,424
Ending balance (in shares) at Jun. 30, 2023		35,781,919